Philip Morris
Risk Management Commentary for Dr. D. Allan Bromley Assistant to the President for Science and Technology
Fields
- Author
- Hart, R.
- Starr, C.
- Wilson, R.
- Starr, C.
- Area
- LOGUE,MAYADA/OFFICE
- Type
- REPT, REPORT, OTHER
- Site
- N426
- Named Person
- Bromley, D.A.
- Request
- Stmn/R1-072
- Document File
- 2025545619/2025546382/Harvard University Office of
- Continuing Education Short Course Program Harvard School
- of Public Health
- Continuing Education Short Course Program Harvard School
- Named Organization
- Congress
- Council on Risk Assessment
- Dod
- Doe
- Dot
- Epa, Environmental Protection Agency
- Executive Office
- FDA, Food and Drug Administration
- Hhs, Dept of Health and Human Services
- Nuclear Regulatory Commission
- Omb
- OSHA, Occupational Safety & Health Administration
- Ostp
- Ostp Council
- Pcast
- Pcast Subcomm
- Risk Assessment + Management Commission
- Senate
- Society for Risk Analysis
- Council on Risk Assessment
- Litigation
- Stmn/Produced
- Characteristic
- EXTR, EXTRA
- Master ID
- 2025545673/6381
Related Documents:- 2025545673-6381 Risk Analysis in Occupational and Environmental Health 910904 - 910906
- 2025545684 Telephone Locations and Protocol
- 2025545689-5696 Risk Assessment for Carcinogens: A Comparison of Approaches of the Acgih and the Epa
- 2025545697 Hps Newsletter Interview with A Risk Expert
- 2025545698-5711 Science and Its Limits: the Regulator's Dilemma
- 2025545713-5721 Risk / Benefit Analysis
- 2025545726-5729 Risk Assessment and Comparisons: An Introduction
- 2025545750-5792 Risk Assessment of Chemical Carcinogens: Is It Time for A Change?
- 2025545795-5799 Tools of Risk Analysis Applications of Epidemiology
- 2025545800-5810 Notice of Intended Changes - Benzene
- 2025545811-5822 Epidemiology in Risk Assessment for Regulatory Policy
- 2025545824-5850 Risk Analysis in Environmental and Occupational Health Use of Animal and Other Data As Predictors of Human Risk
- 2025545851-5871 Risk Analysis in Environmental and Occupational Health Uncertainties in Predicting Human Risks
- 2025545872-5881 How Do Cancer Risks Predicted From Animal Bioassays Compare with the Epidemiologic Evidence? the Case of Ethylene Dibromide
- 2025545882-5887 Use of Biological Assays in Short-Term Assessment of Inhaled Substances
- 2025545888
- 2025545889-5891 Risk Analysis in Environmental and Occupational Health Are Your Mushrooms Safe to Eat?
- 2025545892-5899 the Rat As An Experimental Animal
- 2025545901-5907 Non-Cancer Endpoints
- 2025545910-5939 Cancer Facts & Figures - 890000
- 2025545940-5941 Cancer Facts & Figures - 890000
- 2025545942-5944 Get - the - Lead - Out Guru Challenged A Decade-Old Scientific Argument Over the Effects of Low-Level Lead on Iq Turns Nasty Following Allegations of Misconduct
- 2025545945-5948
- 2025545949-5958 the Question of Thresholds for Radiation and Chemical Carcinogenesis
- 2025545959-5980 Are There Thresholds for Carcinogenesis? the Thorny Problem of Low-Level Exposure
- 2025545981-5990 Perspectives on Comparing Risks of Environmental Carcinogens
- 2025545991-5998 Acceptable Cancer Risks: Probabilities and Beyond
- 2025546000-6011 Ideas in Pathology Pivotal Role of Increased Cell Proliferation in Human Carcinogenesis
- 2025546012-6017 Cell Proliferation in Carcinogenesis
- 2025546019-6027 the Role of Expert Judgement in Risk Analysis
- 2025546029-6039 the Respiratory Tract As A Route of Exposure
- 2025546040-6045 the Respiratory Tract As A Portal of Entry for Toxic Particles
- 2025546047-6062 Limitations to the Use of Employee Exposure Data on Air Contaminants in Epidemiologic Studies
- 2025546063-6083 Benefit - Cost Analysis of Environmental Regulation: Case Studies of Hazardous Air Pollutants
- 2025546086-6089 Legislative and Regulatory Aspects of Risk
- 2025546090-6099 Connecticut's Dioxin Ambient Air Quality Standard
- 2025546100-6103
- 2025546105 Annals of Radiation Calamity on Meadow Street
- 2025546106 Caution Urged When Using Insect Repellents
- 2025546116 Volatile Organics and Inorganics Action Levels 900400
- 2025546134-6135 Summary of Radon Test Results of the Household Testing Program
- 2025546141-6145 Introduction to Discussion Sessions
- 2025546146-6149 Risk Assessment in Environmental and Occupational Health Risk of Alar (Daminozide)
- 2025546150-6160 Intolerable Risk: Pesticides in Our Children's Food
- 2025546161-6162 Pesticides, Risk, and Applesauce
- 2025546163-6168 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546169 Daminozide / Udmh
- 2025546170-6172 the Relative Risk of Daminozide (Alar / Kylar) Use
- 2025546173 Be Most Wary of Nature's Own Pesticides
- 2025546174-6175 A Movie Star Pares the Apple Industry
- 2025546176-6183 Summary of Toxicology Data on Daminozide and Udmh
- 2025546184-6194 Attachment I Graphs of Data From NCI / Ntp 83 Daminozide
- 2025546195-6196
- 2025546197-6202 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546203-6224 Regulatory Decision - Making Under Uncertainty: the Case of Alar
- 2025546226 Epa Moves to Reassess the Risk of Dioxin Urged on by the Scientific Community, Epa Is Developing A New Model for Estimating Dioxin's Risk
- 2025546227 US Government Orders New Look at Dioxin the Environmental Protection Agency Is Evaluating Data From the Past Decade That Suggest Dioxin's Toxicity May Be Overestimated. A Risk Assessment Model Based on Biological Mechanism Is Being Drawn Up.
- 2025546228-6235 Dioxin Toxicity: New Studies Prompt Debate, Regulatory Action New Data on Dioxin's Effect on Humans, A Clearer Picture of the Cellular Events It Precipitates, and New Animal Toxicity Studies May Provide Epa with A Firm Basis for Regulation
- 2025546236-6250 the Regulation of Gene Expression by 2,3,7, 8-Tetrachlorodibenzo-P-Dioxin
- 2025546251-6253 Dioxin Risks Revisited Armed with A New Understanding of How Dioxin Works on the Molecular Level, A Number of Scientists Are Challenging Epa to Change the Way It Does Risk Assessment
- 2025546255-6258 Lead Toxicity Case Study for Short Course on Risk Analysis in Occupational and Environmental Health 910904 - 910906
- 2025546259-6267 Lead
- 2025546268-6275 Lead in Bone: Implications for Toxicology During Pregnancy and Lactation
- 2025546276-6281 the Long-Term Effects of Exposure to Low Doses of Lead in Childhood An 11 - Year Follow-Up Report
- 2025546282-6285
- 2025546298-6321 Review 890000 Alice Hamilton Lecture Lead and Human Health:Background and Recent Findings
- 2025546323-6348 Traps and Errors in Risk Analysis
- 2025546349-6356 Health Risks the Perception of Reality and the Realty of Perception
- 2025546357-6362 Communicating Risk Under Title III of Sara: Strategies for Explaining Very Small Risks in A Community Context
- 2025546363-6368 Industrial Risk Perceptions
- 2025546369-6370 Too Many Rodent Carcinogens: Mitogenesis Increases Mutagenesis
- 2025546371-6373 Has Risk Assessment Become Too 'conservative'?
- 2025546374-6378 Health and Safety Risk Analyses: Information for Better Decisions
- 2025546379-6381 Telling Reporters About Risk Dealing with Reporters Needn't Be the Least Agreeable Part of the Job.
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- yjp02a00
Document Images
Risk Management Commentary
for
Dr. D. Allan Bromley
Assistant to the President
for
Science and Technology
I. I'residential Obj ectives:
1. The very best science should determine the allocation of resources. Public
fears drive much of regulatory and Congressional actions. These public
concerns are often inconsistent with science-based selection of those factors
most effective in improving public health.
2. Coherent policies, methodologies, and procedures for establishing regulatory
objectives of the federal agencies on a scientific basis. These should
effectively incorporate current science, peer review, and public participation.
3. Maximize the effectiveness of our huge national expenditures arising from
regulations for improving health and safety by a balanced allocation of
priorities and resources.
4. Minimize congressional prescriptions on details of risk management to give
the agencies more flexibility to meet regulatory objectives with minimal
impact on economic activities.
II. Recommendations:
1. Appoint a deputy for a full-time focus on Risk Assessment and Management.
Select someone who understands the complexities of the issues.
2. Establish a Council (or PCAST Subcommittee) on Risk Assessment and
Management for review and guidance of agency criteria, methodologies and
procedures. This would provide scientific oversight on proposed agency
activities and regulations. It would also coordinate the large number of
existing government committees and programs already engaged on specific
agency tasks..
3. Coordinate with OMB on the process for economic evaluations and agency
implementation of OMB procedural recommendations.

4. Ini.t.iate a public education program on the realities of risks and choices (both
governmental and individual), comparative risks, benefit-risk balance, and
the acceptability of low-level exposures in daily life. The Society for Risk
Analysis may be a vehicle for such a program. Modest financial support
would be needed for workshops, bulletins, teaching material, etc.
III. Background Issues:
The cumulative national direct cost burden of proposed reductions of
environmental risks is likely to exceed $100 billions per year (e.g. clean air, toxic,
CFCs, (:02, electricity fields, house radon, hazardous waste, etc.). Indirect costs
will increase this burden. These costs will become publicly apparent through
their large inflationary effect on costs. They cannot be ignored. Unfortunately,
there is no upper bound to such expenditures as long as "zero" risk is the
political target, except a national resource limitation. Recognizing that poverty
is the greatest social pollutant, the effect on the productivity of the economy
must be considered.
Congre~,s has implied in several acts that the cost of meeting health and safety
objectives should not be considered in setting regulatory objectives. However,
this does not preclude the establishment of regulatory targets consistent with the
optimal distribution of our resources to improve health and safety. This is a
central issue, as it is the operational intersection of risk assessment with risk
management. Even a crude disclosure of the relative importance of risks might
diminish the prescriptive tendencies of Congress, and shift the decision
initiatives to the agencies on the allocation of funds and attention.
Public confidence in the wisdom, objectivity, credibility, and feasibility of
goverru-n.ent regulatory actions is an essential objective. This requires that the
suggested OSTP Council be broadly based with expertise from all stakeholders
(academia, government, industry, public groups, etc.) and is constituted to
consider risk assessment, management, and communication. Obviously, such a
Council would need staff support for organizing briefings, discussions, and
fundings.
CS/dt/Papers/Bromley/Version 2/Revised
2

IV. Risk Assessment:
The quantitative establishment of the relationship between public exposure to a
hazard and its health and safety consequences suffers from several handicaps.
1. Analytic uncertainties become larger as the exposure levels per person
becomes smaller because the data base becomes vague and finally
nonexistent. At the same time, the number of people involved tends to
increase, so the cumulative public risk becomes indeterminate. As a substitute
for scientific information, agencies use simplified extrapolations of high level
da.ta and "worst case" projections for regulatory purposes.
2. The agencies treat each hazard as an independent source of risk, and use
fixed criteria for setting targets (e.g. EPA's 1 in a million lifetime risk).
Comparative risk analysis is generally absent, although implicit balancing of
the :public perceptions of the relative importance of risks is subconsciously
involved in agency attention.
3. The "worst case" syndrome pervades agency decisions. Given the
uncertainties of the data, it is easier to publicly defend a "worst case" choice.
However, the economic consequences may be extremely large, particularly
when orders of magnitude are involved.
4. It is :impossible to consistently use "worst case" analysis. Agencies tend to
apply "worst case" projections to selected situations they choose to analyze,
and to ignore the actual risks of unanalyzed hazards. This tends to make
regulation arbitrary, capricious, and independent of the actual risk.
V. Risk Management:
1. There are no generally accepted measures as yet developed to compare the
unlike consequences of a variety of risks (e.g. life threatening vs physical
impairment, human vs ecologic, physical vs psychological, short term vs long
term, etc). Nevertheless, such implicit evaluations are being made, and are
shaped by the cultural biases of the decision makers.
2. There are no guidelines for comparative cost-effectiveness of the remedial
measures imposed by regulations to achieve improvement in health or
ecology, or of the reduction of involuntary exposures to risks. Regulations
CS/dt/Papers/Bromley/Version 2/Revised
3

are usually justified on the basis of individual risk reductions, without
re,Fe,rence to the comparative cost-effectiveness of other risk reduction
measures.
3. The responsibility for the implementation of risk management is shared in
practice between government, industry, and the public. This is a very
com.plicated interaction and can only be successful if all sectors agree on the
obj1ectives. In this respect, the Nuclear Regulatory Commission has pioneered
in a sharing of responsibilities with the industry. It should be studied as a
developing risk management system.
4. The individual exposure to risks arises from food, water, air, industry, life-
style systems, work, etc. Many federal agencies are involved (FDA, EPA,
NR.C:, HHS, OSHA, DOE, DOD, DOT,etc). The need for an Executive Office
guidance and overview has been growing during this past decade.
5. The financial consequences of risk management regulations may be one of
our largest national cost factors, indirectly comparable to health services and
defense. It requires a scientific basis for rational decision making. It deserves
OST]P attention at the highest level.
6. The'Senate version of the Clean Air Act, S.1630, contains a long section on the
establishment of a 10 member Risk Assessment and Management
Commission. As presently proposed, this Commission reports to the
President and Congress. It is intended to have a 4 year life. If this legislation
is passed, its relationship to PCAST and the OSTP should be considered. This
proposed Commission is focussed on air pollution., The OSTP interest
shou]',d encompass the wider spectrum of risks covered by other federal
agencies.
Presented by:
August, 1990 R.
C.
R. Hart,
Starr,
Wilson
and
CS/dt/PapersBromley/Version 2/Revised
4
